Dafna D Gladman

Dafna D Gladman

UNVERIFIED PROFILE

Are you Dafna D Gladman?   Register this Author

Register author
Dafna D Gladman

Dafna D Gladman

Publications by authors named "Dafna D Gladman"

Are you Dafna D Gladman?   Register this Author

100Publications

1809Reads

17Profile Views

Is axial psoriatic arthritis distinct from ankylosing spondylitis with and without concomitant psoriasis?

Rheumatology (Oxford) 2020 Jun;59(6):1340-1346

Krembil Research Institute, Toronto Western Hospital, University Health Network.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/rheumatology/kez457DOI Listing
June 2020

Impact of the new American College of Cardiology/American Heart Association definition of hypertension on atherosclerotic vascular events in systemic lupus erythematosus.

Ann Rheum Dis 2020 May 10;79(5):612-617. Epub 2020 Mar 10.

Center for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital, University of Toronto, Lupus Clinic, Toronto, Ontario, Canada

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/annrheumdis-2019-216764DOI Listing
May 2020

Identifying a response for the systemic lupus erythematosus disease activity glucocorticoid index (SLEDAI-2KG).

Arthritis Care Res (Hoboken) 2020 May 20. Epub 2020 May 20.

University of Toronto Lupus Clinic, Centre for Prognosis Studies in Rheumatic Diseases, Toronto Western Hospital, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/acr.24261DOI Listing
May 2020

Mortality in psoriatic arthritis: Risk, causes of death, predictors for death.

Semin Arthritis Rheum 2020 May 23;50(4):571-575. Epub 2020 May 23.

Centre for Prognostic Studies in the Rheumatic Diseases, Toronto Western Hospital, University of Toronto, Toronto, ON Canada; Institute of Medical Science, University of Toronto, Toronto, ON Canada. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.semarthrit.2020.04.001DOI Listing
May 2020

Development of a Modified Psoriatic Arthritis Disease Activity Score Using the Medical Outcomes Study Short Form 12 as a Measure of Quality of Life.

Arthritis Care Res (Hoboken) 2020 Apr 12;72(4):577-582. Epub 2020 Mar 12.

University of Toronto and the Krembel Research Institute, University Health Network, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/acr.23876DOI Listing
April 2020

Secukinumab Immunogenicity over 52 Weeks in Patients with Psoriatic Arthritis and Ankylosing Spondylitis.

J Rheumatol 2020 Apr 15;47(4):539-547. Epub 2019 Jun 15.

From the Division of Arthritis & Rheumatic Diseases, Rheumatology Clinics, Oregon Health & Science University, Portland, Oregon, USA; Health Network, Centre for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital, Toronto, Ontario, Canada; Centre for Rheumatic Diseases, Institute of Infection, Immunity and Inflammation, University of Glasgow, Glasgow, UK; PKS Bioanalytics, Novartis Institutes for Biomedical Research, Basel; Immunology and Dermatology, Novartis Pharma AG, Basel, Switzerland; Immunology and Dermatology, Novartis Pharmaceuticals Corp., East Hanover, New Jersey, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.190116DOI Listing
April 2020

Impact of disease activity on organ damage progression in systemic lupus erythematosus: University of Toronto Lupus Clinic Cohort.

J Rheumatol 2020 Apr 1. Epub 2020 Apr 1.

From the Centre for Prognosis Studies in Rheumatic Diseases, Toronto Western Hospital, Toronto, Ontario, Canada; GlaxoSmithKline Inc., Toronto, ON, Canada; GlaxoSmithKline Inc., Philadelphia, PA, USA.
This study was funded by GlaxoSmithKline (GSK; study number 201390).
JART and SM are employees of GSK. AS was an employee of GSK at the time of the study. AS and JART hold stocks in GSK. SI was an employee of GSK during the development of the manuscript. MBU has received consulting fees and research grants from GSK, UCB, and Eli Lilly. DDG reports consulting for GSK, BMS, Janssen, UCB, and Eli Lilly. DI and JS have nothing to declare.
Address correspondence to Professor Murray B. Urowitz Toronto Western Hospital, 399 Bathurst Street, 1E409, Toronto, Ontario M5T 2S8, Canada. Email:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.190259DOI Listing
April 2020

Advanced Chronic Kidney Disease in Lupus Nephritis: Is Dialysis Inevitable?

J Rheumatol 2020 Apr 1. Epub 2020 Apr 1.

From the Centre for Prognosis Studies in Rheumatic Diseases, Toronto Lupus Clinic, University Health Network, Toronto, Ontario, Canada. Address correspondence to Murray B. Urowitz, MD, FRCPC University of Toronto Lupus Clinic Centre for Prognosis Studies in the Rheumatic Diseases Toronto Western Hospital, 399 Bathurst St. 1E-410B, Toronto, Ontario, M5T 2S8, Canada. Email:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.191064DOI Listing
April 2020

Treating Psoriatic Arthritis to Target: Defining the Psoriatic Arthritis Disease Activity Score That Reflects a State of Minimal Disease Activity.

J Rheumatol 2020 Mar 15;47(3):362-368. Epub 2019 Jun 15.

From the Faculty of Medicine; Dalla Lana School of Public Health; Department of Surgery; Division of Rheumatology, Department of Medicine; Institute of Medical Science; Department of Laboratory Medicine and Pathobiology, University of Toronto; Health Care & Outcomes Research and Arthritis Program, Krembil Research Institute, University Health Network, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.181472DOI Listing
March 2020

Treatment guidelines in psoriatic arthritis.

Rheumatology (Oxford) 2020 Mar;59(Supplement_1):i37-i46

University of Toronto, Department of Medicine, University of Toronto, Toronto Western Hospital, Krembil Research Institute, Toronto, ON, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/rheumatology/kez383DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7065461PMC
March 2020

Appraisal of candidate instruments for assessment of the physical function domain in patients with psoriatic arthritis.

J Rheumatol 2020 Feb 1. Epub 2020 Feb 1.

From the Singapore General Hospital, Duke-NUS Medical School, Singapore; Division of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA; Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA; Musculoskeletal Statistics Unit, The Parker Institute, Bispebjerg and Frederiksberg Hospital, Denmark; Concord Repatriation General Hospital, Sydney, Australia; Duke University School of Medicine, Durham, North Carolina, USA; Hong Kong Psoriatic Arthritis Association, Hong Kong, China; Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, United Kingdom; Division of Immunology/Rheumatology, Stanford University School of Medicine, Palo Alto, California, USA; Division of Rheumatology, University of Toronto, Toronto, Ontario, Canada; Swedish Medical Center/Providence St Joseph Health and University of Washington School of Medicine, Seattle, Washington, USA; Research Unit of Rheumatology, Department of Clinical Research, University of Southern Denmark, Odense University Hospital, Denmark; Royal National Hospital for Rheumatic Diseases, University of Bath, Bath, United Kingdom. Correspondence to: Ying-Ying Leung, MB ChB, M.D.; Department of Rheumatology and Immunology, Singapore General Hospital, The Academia, level 4, 20 College Road, Singapore 169856, Contact No.: +65 63265276, Fax no.: +65 62203321, E-mail:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.191119DOI Listing
February 2020

Assessing structural damage progression in psoriatic arthritis and its role as an outcome in research.

Arthritis Res Ther 2020 02 3;22(1):18. Epub 2020 Feb 3.

Swedish Medical Center/Providence St. Joseph Health and University of Washington, 601 Broadway Suite 600, Seattle, WA, 98122, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13075-020-2103-8DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6998345PMC
February 2020

Identifying and characterizing psoriasis and psoriatic arthritis patients in Ontario administrative data: a population-based study from 1991 to 2015.

J Rheumatol 2020 Feb 15. Epub 2020 Feb 15.

From the University of Toronto and Women's College Research Institute, Women's College Hospital, Toronto, ON, Canada; University of Toronto, Institute of Health Policy, Management and Evaluation and Sunnybrook Research Institute, Institute for Clinical Evaluative Sciences, Toronto, Ontario, Canada;, Department of Medicine, University of Toronto and Toronto Western Hospital, Toronto, ON, Canada; University of Toronto and Sunnybrook Research Institute, Sunnybrook Hospital, Toronto, Ontario, Canada; ICES, Toronto, ON, Canada; Divisions of Rheumatology and Clinical Epidemiology, Research Institute of the McGill University Health Centre, Montreal, QC, Canada; Krembil Research Institute, Director, Psoriatic Disease Program, University Health Network, Toronto Western Hospital, Toronto, ON, Canada; Institute of Health Policy, Management, and Evaluation, University of Toronto; and Institute for Clinical Evaluative Sciences, Toronto, ON, Canada; University of Toronto, Department of Family Medicine, Toronto, ON, Canada. The study was supported by grants from the International Psoriasis and Arthritis Team (IPART) and the Canadian Rheumatology Association (Canadian Initiative for Outcome in Rheumatology cAre (CIORA)). Lihi Eder is supported by a New Investigator Salary Award from the Arthritis Society. Karen Tu is supported by a research scholar award by the Department of Family and Community Medicine at the University of Toronto. This study was supported by ICES, which is funded by an annual grant from the Ontario Ministry of Health and Long-Term Care (MOHLTC). Parts of this material are based on data and information compiled and provided by the MOHLTC and the Canadian Institute for Health Information. The analyses, conclusions, opinions and statements expressed herein are solely those of the authors and do not reflect those of the funding or data sources; no endorsement is intended or should be inferred. Address correspondence to Dr Lihi Eder Women's College Hospital, 76 Grenville Street, Toronto, ON, Canada, M5S 1B2. Email:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.190659DOI Listing
February 2020

Remission in psoriatic arthritis: Definition and predictors.

Semin Arthritis Rheum 2020 Feb 3. Epub 2020 Feb 3.

Division of Rheumatology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada; Psoriatic Arthritis Program, University Health Network, Centre for Prognosis Studies in The Rheumatic Diseases, Toronto Western hospital, Toronto, Ontario, Canada. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.semarthrit.2020.01.012DOI Listing
February 2020

Atherosclerotic Vascular Events in Systemic Lupus Erythematosus: An Evolving Story.

J Rheumatol 2020 Jan 1;47(1):66-71. Epub 2019 Feb 1.

From the University of Toronto Lupus Clinic, Centre for Prognosis Studies in The Rheumatic Disease, Toronto Western Hospital, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.180986DOI Listing
January 2020

Construction of a Frailty Index as a Novel Health Measure in Systemic Lupus Erythematosus.

J Rheumatol 2020 Jan 15;47(1):72-81. Epub 2019 Apr 15.

From the Divisions of Rheumatology and Geriatric Medicine, Department of Medicine, Dalhousie University; Department of Community Health and Epidemiology, Dalhousie University, Halifax, Nova Scotia; Divisions of Rheumatology and Clinical Epidemiology, Department of Medicine, McGill University, Montreal; Division of Rheumatology, Centre Hospitalier Universitaire (CHU) de Québec et Université Laval, Quebec City, Quebec; Division of Rheumatology, Cumming School of Medicine, University of Calgary, Calgary, Alberta; Center for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital and University of Toronto, Toronto, Ontario; University of Manitoba, Winnipeg, Manitoba; Division of Rheumatology, Department of Medicine and Department of Pathology, Queen Elizabeth II Health Sciences Center and Dalhousie University, Halifax, Nova Scotia, Canada; Department of Rheumatology, Hanyang University Hospital for Rheumatic Diseases, Seoul, Korea; Rheumatology Research Group, School of Immunity and Infection, College of Medical and Dental Sciences, University of Birmingham, Birmingham; Arthritis Research UK Epidemiology Unit, Faculty of Biology Medicine and Health, Manchester Academic Health Sciences Center, The University of Manchester, and National Institute for Health Research (NIHR) Manchester Musculoskeletal Biomedical Research Centre, Manchester University National Health Service (NHS) Foundation Trust, Manchester Academic Health Science Center, Manchester; Center for Rheumatology, Department of Medicine, University College London, London; Lanarkshire Center for Rheumatology, Hairmyres Hospital, East Kilbride, Scotland; Lupus Research Unit, The Rayne Institute, St Thomas' Hospital, King's College London School of Medicine, London, UK; Instituto Nacional de Ciencias Medicas y Nutrición, Mexico City, Mexico; Cedars-Sinai/David Geffen School of Medicine at University of California Los Angeles (UCLA), Los Angeles, California; Department of Clinical Pharmacology, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma; Department of Medicine, State University of New York (SUNY) Downstate Medical Center, Brooklyn, New York; Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama; Division of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, Maryland; Thurston Arthritis Research Center, University of North Carolina, Chapel Hill, North Carolina; Northwestern University and Feinberg School of Medicine, Chicago, Illinois; Lupus Center of Excellence, Allegheny Health Network, Pittsburgh, Pennsylvania; Feinstein Institute for Medical Research, Manhasset, New York; Emory University School of Medicine, Division of Rheumatology, Atlanta, Georgia; Medical University of South Carolina, Charleston, South Carolina; University of California San Diego School of Medicine (UCSD), La Jolla, California; Hospital for Joint Diseases, New York University (NYU), Seligman Center for Advanced Therapeutics, New York, New York, USA; Autoimmune Diseases Research Unit, Department of Internal Medicine, BioCruces Health Research Institute, Hospital Universitario Cruces, University of the Basque Country, Barakaldo; Josep Font Autoimmune Diseases Laboratory, IDIBAPS, Department of Autoimmune Diseases, Hospital Clínic, Barcelona, Spain; Division of Rheumatology, Department of Internal Medicine, Istanbul Medical Faculty, Istanbul University, Istanbul, Turkey; Unit for Clinical Therapy Research (ClinTRID), Karolinska Institute, Stockholm; Department of Clinical Sciences Lund, Rheumatology, Lund University, Lund, Sweden; Copenhagen Lupus and Vasculitis Clinic, Section 4242, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.

View Article

Download full-text PDF

Source
http://www.jrheum.org/lookup/doi/10.3899/jrheum.181338
Publisher Site
http://dx.doi.org/10.3899/jrheum.181338DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6800806PMC
January 2020

The relationship between patient acceptable symptom state and disease activity in patients with psoriatic arthritis.

Rheumatology (Oxford) 2020 01;59(1):69-76

Psoriatic Arthritis Program, Centre for Prognosis Studies in the Rheumatic Diseases, Krembil Research Institute, University Health Network, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/rheumatology/kez202DOI Listing
January 2020

Health Care Utilization for Musculoskeletal Issues During the Pre-diagnosis Period in Psoriatic Arthritis - A Population-Based Study.

Arthritis Care Res (Hoboken) 2020 Jan 21. Epub 2020 Jan 21.

University of Toronto, Institute of Health Policy, Management and Evaluation; Scientist, Sunnybrook Research Institute, ICES, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/acr.24146DOI Listing
January 2020

Epigenome-wide analysis of sperm cells identifies IL22 as a possible germ line risk locus for psoriatic arthritis.

PLoS One 2019 19;14(2):e0212043. Epub 2019 Feb 19.

Psoriatic Arthritis Program, Centre for Prognosis Studies in the Rheumatic Diseases, Krembil Research Institute, University Health Network, Toronto, ON, Canada.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0212043PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6380582PMC
November 2019

A novel role for the psoriatic arthritis impact of disease (PsAID) questionnaire.

Semin Arthritis Rheum 2019 10 19;49(2):241-245. Epub 2019 Apr 19.

Centre for Prognosis Studies in the Rheumatic Diseases, Krembil Research Institute, Toronto Western Hospital, Institute of Medical Science, University Health Network, 399 Bathurst Street 1E-410B, Toronto M5T 2S8, Ontario, Canada. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.semarthrit.2019.04.001DOI Listing
October 2019

Dr. Tselios, reply.

J Rheumatol 2019 10 1;46(10):1422. Epub 2019 Jul 1.

Toronto Lupus Clinic, Centre for Prognosis Studies in Rheumatic Diseases, University Health Network, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.190255DOI Listing
October 2019

Liver Abnormalities in Patients with Psoriatic Arthritis.

J Rheumatol 2019 Oct 15. Epub 2019 Oct 15.

From the Psoriatic Arthritis Program, Centre for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital, University Health Network, Toronto; Department of Statistics and Actuarial Science, University of Waterloo, Waterloo; University of Toronto, Department of Medicine, Division of Rheumatology, University of Toronto, Toronto; Krembil Research Institute, Toronto Western Hospital, University Health Network, Toronto, Ontario, Canada; Rheumatic Disease Unit, Department of Internal Medicine, Phramongkutlao Hospital and College of Medicine, Bangkok, Thailand. The Psoriatic Arthritis Program is funded in part by The Arthritis Society, Canadian Institutes of Health Research, and the Krembil Foundation. R. Pakchotanon, MD, Centre for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital, and Rheumatic Disease Unit, Department of Internal Medicine, Phramongkutlao Hospital and College of Medicine; J.Y. Ye, Biostatistician, Centre for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital; R.J. Cook, PhD, Professor, Department of Statistics and Actuarial Science, University of Waterloo; V. Chandran, MBBS, MD, DM, PhD, Assistant Professor, University of Toronto, Department of Medicine, Division of Rheumatology, University of Toronto, Co-Director, Psoriatic Arthritis Program, Centre for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital, University Health Network; D.D. Gladman, MD, FRCPC, Director, Psoriatic Arthritis Program, Centre for Prognosis Studies in the Rheumatic Diseases, Senior Scientist, Krembil Research Institute, Toronto Western Hospital, University Health Network. Address correspondence to Dr. D.D. Gladman, Psoriatic Arthritis Program, Centre for Prognosis Studies in the Rheumatic Diseases, Krembil Research Institute, University Health Network, 399 Bathurst St., 1E410B, Toronto, Ontario M5T 2S8, Canada. E-mail: Accepted for publication September 24, 2019.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.181312DOI Listing
October 2019

Effect of Secukinumab on the Different GRAPPA-OMERACT Core Domains in Psoriatic Arthritis: A Pooled Analysis of 2049 Patients.

J Rheumatol 2019 Oct 15. Epub 2019 Oct 15.

From the Johns Hopkins University School of Medicine, Baltimore, Maryland, USA; University of Glasgow, Glasgow; University of Oxford, Oxford, UK; Cleveland Clinic, Cleveland, Ohio, USA; Toronto Western Research Institute and University of Toronto, Toronto, Ontario, Canada; Sorbonne Université, Institut Pierre Louis d'Epidémiologie et de Santé Publique; Pitié Salpêtrière Hospital, AP-HP, Paris, France; Novartis Pharmaceuticals Corporation, East Hanover, New Jersey; Swedish Medical Center/Providence St. Joseph Health and University of Washington, Seattle, Washington, USA. This study was funded by Novartis Pharmaceuticals Corp., East Hanover, New Jersey, USA, which manufactures secukinumab. A.M. Orbai is a Jerome L. Greene Foundation Scholar and is supported in part by a research grant from the US National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health under award number P30-AR070254 (Core B), a Rheumatology Research Foundation Scientist Development Award, and a Staurulakis Family Discovery Award. A.M. Orbai has received grant support and consulting fees from Novartis. I.B. McInnes has received consulting fees from Novartis. L.C. Coates has received grant support, consulting fees, and speakers bureau fees from Novartis. D.D. Gladman has received grant support and consulting fees from Novartis. L. Gossec has received consulting fees from Novartis. L. Pricop, O. Chambenoit, and X. Meng are employees and stockholders of Novartis. P.J. Mease has received research grants, consulting fees, and speakers bureau fees from Novartis. A.M. Orbai, MD, MHS, Johns Hopkins University School of Medicine; I.B. McInnes, MD, PhD, University of Glasgow; L.C. Coates, MBChB, PhD, University of Oxford; M.E. Husni, MD, MPH, Cleveland Clinic; D.D. Gladman, MD, FRCPC, Toronto Western Research Institute and University of Toronto; L. Gossec, MD, PhD, Sorbonne Université, Institut Pierre Louis d'Epidémiologie et de Santé Publique, and Pitié Salpêtrière Hospital, AP-HP; L. Pricop, MD, Novartis Pharmaceuticals Corp.; O. Chambenoit, PhD, Novartis Pharmaceuticals Corp.; X. Meng, PhD, Novartis Pharmaceuticals Corp.; P.J. Mease, MD, Swedish Medical Center/Providence St. Joseph Health and University of Washington. Address correspondence to Dr. A.M. Orbai, Assistant Professor of Medicine, Johns Hopkins University School of Medicine, Division of Rheumatology, MFL Center Tower, Suite 4100, 5200 Eastern Ave., Baltimore, Maryland 21224, USA. E-mail: Full Release Article. For details see Reprints and Permissions at jrheum.org. Accepted for publication September 27, 2019.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.190507DOI Listing
October 2019

Radiographic Progression According to Baseline C-reactive Protein Levels and Other Risk Factors in Psoriatic Arthritis Treated with Tofacitinib or Adalimumab.

J Rheumatol 2019 09 1;46(9):1089-1096. Epub 2019 Mar 1.

From the Department of Rheumatology, Leiden University Medical Center, Leiden, the Netherlands; Department of Rheumatology, University of Toronto, Toronto Western Hospital, Toronto, Ontario, Canada; Department of Rheumatology, St. Vincent's University Hospital, Dublin, Ireland; Division of Rheumatology, Allergy, and Immunology, University of California, San Diego School of Medicine, La Jolla, San Diego, California, USA; Pfizer Inc., Groton, Connecticut, USA; Pfizer Inc., Montreal, Quebec, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.180971DOI Listing
September 2019

2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus.

Ann Rheum Dis 2019 09 5;78(9):1151-1159. Epub 2019 Aug 5.

Internal Medicine Department, Centre de référence maladies auto-immunes et systémiques rares d'île deFrance, Cochin Hospital, Université Paris Descartes-Sorbonne Paris Cité, INSERM U1153, Center for Epidemiology and Statistics Sorbonne Paris Cité (CRESS), Paris, France

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/annrheumdis-2018-214819DOI Listing
September 2019

2019 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus.

Arthritis Rheumatol 2019 09 6;71(9):1400-1412. Epub 2019 Aug 6.

Toronto Western Hospital, University Health Network, Mount Sinai Hospital, University of Toronto, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/art.40930DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6827566PMC
September 2019

PsAID12 Provisionally Endorsed at OMERACT 2018 as Core Outcome Measure to Assess Psoriatic Arthritis-specific Health-related Quality of Life in Clinical Trials.

J Rheumatol 2019 08 15;46(8):990-995. Epub 2018 Dec 15.

From the Division of Rheumatology, Johns Hopkins University School of Medicine, Baltimore; Department of Medicine, Duke University School of Medicine, Durham, North Carolina; Kezar Life Sciences, South San Francisco; Division of Immunology, Stanford University, Palo Alto, California; Rheumatology Research, Swedish Medical Center and University of Washington School of Medicine, Seattle, Washington; Global Patient Outcomes and Real World Evidence, Eli Lilly and Co., Indianapolis, Indiana; University of Pennsylvania, Philadelphia, Pennsylvania; Department of Dermatology, University of Utah, Salt Lake City, Utah, USA; Royal Prince Alfred Hospital Medical Centre, Sydney, Australia; Department of Rheumatology and Immunology, Singapore General Hospital, Singapore; Royal National Hospital for Rheumatic Diseases, Bath; Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK; Musculoskeletal Statistics Unit: The Parker Institute, Bispebjerg and Frederiksberg Hospital, Copenhagen; Department of Rheumatology, Odense University Hospital, Odense, Denmark; Sorbonne Université; Rheumatology Department, Pitié Salpêtrière Hospital, AP-HP, Paris, France; VU Medical Centre, Amsterdam, the Netherlands; Global Medical Affairs, Pfizer Inc., Montreal, Quebec; Clinical Epidemiology Program, Ottawa Hospital Research Institute; Division of Rheumatology, Department of Medicine, and School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa; Musculoskeletal Health and Outcomes Research, St. Michael's Hospital and Institute for Work and Health; Department of Occupational Science and Occupational Therapy, Rehabilitation Sciences Institute, Institute for Health Policy Management and Evaluation, University of Toronto; University of Toronto; Krembil Research Institute; Psoriatic Arthritis Program, University Health Network, Toronto, Ontario, Canada; Department of Rheumatology, St. Vincent's University Hospital and Conway Institute for Biomolecular Research, University College Dublin, Dublin, Ireland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.181077DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6571063PMC
August 2019

Endorsement of the 66/68 Joint Count for the Measurement of Musculoskeletal Disease Activity: OMERACT 2018 Psoriatic Arthritis Workshop Report.

J Rheumatol 2019 08 15;46(8):996-1005. Epub 2019 Feb 15.

From the Division of Rheumatology, Department of Medicine, and the Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, Minnesota; Division of Rheumatology, Department of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania; Division of Rheumatology, Duke University School of Medicine, Durham, North Carolina; Kezar Life Sciences, South San Francisco; Amgen Inc., Thousand Oaks, California; Swedish-Providence-St. John's Health Systems and University of Washington, Seattle, Washington; Division of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA; Department of Rheumatology and Immunology, Singapore General Hospital, Singapore, Singapore; University of Leeds, Leeds; University of Oxford, Oxford; Royal National Hospital for Rheumatic Diseases; University of Bath, Bath, UK; Musculoskeletal Health and Outcomes Research, St. Michael's Hospital; Institute for Work and Health; Department of Occupational Science and Occupational Therapy, Rehabilitation Sciences Institute and the Institute for Health Policy Management and Evaluation, University of Toronto; Department of Medicine, University of Toronto, Women's College Hospital; Department of Medicine, University of Toronto, Toronto Western Hospital, Toronto; Cochrane Musculoskeletal Group, Ottawa Hospital Research Institute, Centre for Practice-Changing Research; School of Epidemiology and Public Health, University of Ottawa, Ottawa, Ontario; Pfizer Inc., Montreal, Quebec, Canada; Musculoskeletal Statistics Unit: The Parker Institute, Bispebjerg and Frederiksberg Hospital, Copenhagen; Department of Rheumatology, Odense University Hospital, Odense, Denmark; Department of Medical Humanities, Patient Research Partner, Amsterdam University Medical Centre, Amsterdam, the Netherlands; Department of Rheumatology, St. Vincent's University Hospital; Conway Institute for Biomolecular Research, University College Dublin, Ireland; Royal Prince Alfred Hospital Medical Centre, Sydney, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.181089DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6776995PMC
August 2019

Predictive Utility of Cardiovascular Risk Prediction Algorithms in Inflammatory Rheumatic Diseases: A Systematic Review.

J Rheumatol 2019 Aug 15. Epub 2019 Aug 15.

From Women's College Research Institute, Women's College Hospital; Centre for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital; Institute of Medical Science, Department of Medicine, and Gerstein Science Information Centre, University of Toronto, Toronto, Ontario, Canada. K. Colaco was supported by an award from the Enid Walker Estate and Women's College Research Institute. L. Eder was supported by a Young Investigator Award from the Arthritis Society. K. Colaco, MSc, Women's College Research Institute, Women's College Hospital, and Centre for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital, and Institute of Medical Science, University of Toronto; V. Ocampo, MD, Centre for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital, and Department of Medicine, University of Toronto; A.P. Ayala, MISt, Gerstein Science Information Centre, University of Toronto; P. Harvey, BMBS, PhD, Women's College Research Institute, Women's College Hospital, and Department of Medicine, University of Toronto; D.D. Gladman, MD, Centre for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital, and Institute of Medical Science, and Department of Medicine, University of Toronto; V. Piguet, MD, PhD, Women's College Research Institute, Women's College Hospital, and Centre for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital, and Department of Medicine, University of Toronto; L. Eder, MD, PhD, Women's College Research Institute, Women's College Hospital, and Department of Medicine, University of Toronto. Address correspondence to Dr. L. Eder, Women's College Research Institute, Room 6326, Women's College Hospital, 76 Grenville St., Toronto, Ontario M5S 1B2, Canada. E-mail: Accepted for publication August 2, 2019.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.190261DOI Listing
August 2019

Use of Consensus Methodology to Determine Candidate Items for Systemic Lupus Erythematosus Classification Criteria.

J Rheumatol 2019 07 15;46(7):721-726. Epub 2018 Dec 15.

From the Division of Rheumatology, Department of Medicine, Toronto Western Hospital, University of Toronto, Toronto; Division of Rheumatology, Department of Medicine, Mount Sinai Hospital, Toronto; University Health Network, and Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada; Division of Rheumatology, Department of Medicine, University of Michigan, Ann Arbor, Michigan; University of California, Los Angeles, Los Angeles; University of California, San Francisco, California; Brigham and Women's Hospital, Boston; Harvard Medical School, Boston, Massachusetts; Medical University of South Carolina, Charleston, South Carolina; Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA; Hospital Clínic, Barcelona, Spain; AP-HP, Cochin Hospital, Internal Medicine Department, Centre de référence maladies auto-immunes et systémiques rares d'île de France, Paris; Université Paris Descartes-Sorbonne Paris Cité, Paris; INSERM U 1153, Center for Epidemiology and Statistics Sorbonne Paris Cité (CRESS), Paris, France; Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin; Berlin Institute of Health, Department of Rheumatology and Clinical Immunology, Berlin; University Medical Center and Faculty of Medicine Carl Gustav Carus, TU Dresden, Dresden, Germany; Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico; National and Kapodestrian University of Athens, and Biomedical Research Foundation of the Athens Academy, Athens, Greece; Department of Medicine, University of Cambridge, Cambridge, UK; University of Pisa, Pisa, Italy; Medical University of Vienna, Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.180478DOI Listing
July 2019

Response to: 'Can biomarkers differentiate psoriatic arthritis from osteoarthritis?' by Tian .

Ann Rheum Dis 2019 Jul 4. Epub 2019 Jul 4.

Department of Medicine, Rheumatology, University of Toronto, Toronto, Ontario, Canada

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/annrheumdis-2019-215762DOI Listing
July 2019

Clinical Remission and Low Disease Activity Outcomes Over 10 Years in Systemic Lupus Erythematosus.

Arthritis Care Res (Hoboken) 2019 06 10;71(6):822-828. Epub 2019 May 10.

University Health Network, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/acr.23720DOI Listing
June 2019

How can we define low disease activity in systemic lupus erythematosus?

Semin Arthritis Rheum 2019 06 16;48(6):1035-1040. Epub 2018 Oct 16.

University of Toronto Lupus Clinic, Centre for Prognosis Studies in Rheumatic Diseases, Toronto Western Hospital, University Health Network, 399 Bathurst St. 1E-410B, Toronto, Ontario M5T 2S8, Canada. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S00490172183048
Publisher Site
http://dx.doi.org/10.1016/j.semarthrit.2018.10.013DOI Listing
June 2019

Serum-based soluble markers differentiate psoriatic arthritis from osteoarthritis.

Ann Rheum Dis 2019 06 25;78(6):796-801. Epub 2019 Mar 25.

Division of Rheumatology, Department of Medicine, University of Toronto, Toronto Western Hospital, Toronto, Ontario, Canada

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/annrheumdis-2018-214737DOI Listing
June 2019

All-cause, cause-specific and age-specific standardised mortality ratios of patients with systemic lupus erythematosus in Ontario, Canada over 43 years (1971-2013).

Ann Rheum Dis 2019 06 16;78(6):802-806. Epub 2019 Apr 16.

Center for Prognosis Studies in the Rheumatic Diseases, Toronto Lupus Clinic, University Health Network, University of Toronto, Toronto, Ontario, Canada

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/annrheumdis-2018-214802DOI Listing
June 2019

Prologue: 2018 Annual Meeting of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA).

J Rheumatol Suppl 2019 Jun;95:1-3

From GRAPPA (Groups for Research and Assessment of Psoriasis and Psoriatic Arthritis), Seattle, Washington; University of Utah, Salt Lake City, Utah; Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York, New York; Kezar Life Sciences, San Francisco, California; Duke University School of Medicine, Durham, North Carolina, USA; University of Toronto; Krembil Research Institute, Toronto Western Hospital, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.190112DOI Listing
June 2019

Proceedings of the 2018 GRAPPA Collaborative Research Network Meeting.

J Rheumatol Suppl 2019 Jun;95:11-19

From the Rheumatology Research Unit, Cambridge University Hospitals National Health Service (NHS) Foundation Trust, Cambridge; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds; Bradford Hospitals NHS Foundation Trust, Bradford, UK; Department of Medicine, Division of Rheumatology, University of Toronto; Krembil Research Institute, Toronto Western Hospital, Toronto, Ontario, Canada; Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania; Swedish Medical Center/Providence-St. Joseph Health, Seattle, Washington; University of Southern California, Los Angeles, California; University of Utah, Salt Lake City, Utah; Division of Allergy, Immunology, and Rheumatology, University of Rochester Medical Center, Rochester, New York, USA; Conway Institute for Biomolecular Research, University College Dublin; Our Lady's Hospice and Care Services; Department of Rheumatology, St. Vincent's University Hospital, Dublin, Ireland; Department of Medical Humanities, Amsterdam University Medical Center, Amsterdam, the Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.190118DOI Listing
June 2019

The GRAPPA-OMERACT Psoriatic Arthritis Working Group at the 2018 Annual Meeting: Report and Plan for Completing the Core Outcome Measurement Set.

J Rheumatol Suppl 2019 Jun;95:33-37

From the Duke-NUS Medical School, Singapore; Department of Rheumatology and Immunology, Singapore General Hospital, Singapore; Division of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, Maryland; Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania; Department of Dermatology, University of Utah, Salt Lake City, Utah; Kezar Life Sciences, San Francisco; Division of Immunology/Rheumatology, Stanford University School of Medicine, Palo Alto, California; Duke University School of Medicine, Durham, North Carolina; Rheumatology Research, Swedish Medical Center and University of Washington School of Medicine, Seattle, Washington, USA; Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford; Royal National Hospital for Rheumatic Diseases, University of Bath, Bath, UK; Amsterdam University Medical Centre, Department of Medical Humanities, Amsterdam, the Netherlands; Women's College Research Institute, Women's College Hospital, Department of Medicine, University of Toronto; Krembil Research Institute; Psoriatic Arthritis Program, University Health Network, Toronto Western Hospital, Toronto, Ontario, Canada; Department of Rheumatology, St. Vincent's University Hospital and Conway Institute for Biomolecular Research, University College Dublin, Dublin, Ireland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.190122DOI Listing
June 2019

Best-practice Indicators in Psoriatic Disease Care.

J Rheumatol Suppl 2019 Jun;95:38-45

From the Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds; Bradford Hospitals National Health Service (NHS) Foundation Trust, Bradford; Global Strategy Group, Healthcare and Life Sciences, KPMG LLP, London; Guy's and St. Thomas' NHS Foundation Trust, Kings College London, London; University of Oxford, Oxford, UK; University of Toronto, Toronto, Ontario; Toronto Western Hospital, Toronto, Ontario, Canada; Rheumatology Unit, Internal Medicine Services, Hospital Italiano de Buenos Aires, Buenos Aires; University Institute Hospital Italiano de Buenos Aires, Buenos Aires; Argentina; Hospital de la Santa Creu I Sant Pau, Universitat Autònoma de Barcelona, Barcelona, Spain; Division of Dermatology and Venereology, Geneva University Hospitals, Geneva; Department of Pathology and Immunology, University of Geneva, Geneva, Switzerland; Research Institute and Comprehensive Center for Inflammation Medicine, University of Luebeck, Luebeck, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.190120DOI Listing
June 2019

GRAPPA 2018 Project Report.

J Rheumatol Suppl 2019 Jun;95:54-57

From Kezar Life Sciences, San Francisco, California; Duke University School of Medicine, Durham, North Carolina, USA; Department of Rheumatology, St. Vincent's University Hospital and Conway Institute for Biomolecular Research, University College Dublin, Dublin, Ireland; University of Toronto; Krembil Research Institute, Psoriatic Arthritis Program, University Health Network, Toronto Western Hospital, Toronto, Ontario, Canada; UK National Institute for Health Research (NIHR), Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds; Bradford Hospitals UK National Health Service (NHS) Foundation Trust, Bradford, UK; University of California at San Diego, La Jolla, California, USA; University of Alberta, Edmonton, Alberta, Canada; Rheumatology Research, Swedish Medical Center; University of Washington School of Medicine, Seattle, Washington, USA; Division of Allergy, Immunology, and Rheumatology, University of Rochester Medical Center, Rochester, New York, USA; Department of Orthopaedics, Rheumatology, and Musculoskeletal Sciences, University of Oxford, Oxford, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.190121DOI Listing
June 2019

Osteopontin and Disease Activity in Patients with Recent-onset Systemic Lupus Erythematosus: Results from the SLICC Inception Cohort.

J Rheumatol 2019 05 15;46(5):492-500. Epub 2019 Jan 15.

From the Rheumatology/Division of Neuro and Inflammation Sciences, Department of Clinical and Experimental Medicine, Linköping University, Linköping; Department of Medicine, Unit of Rheumatology, Karolinska Institutet and Karolinska University Hospital, Stockholm; Department of Clinical Sciences Lund, Section of Rheumatology, Lund University, Lund; Unit for Clinical Therapy Research (ClinTRID), Karolinska University, Stockholm, Sweden; Centre for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital and University of Toronto, Toronto, Ontario; Division of Rheumatology, Centre Hospitalier Universitaire (CHU) de Québec - Université Laval, Quebec City, Quebec; Division of Rheumatology, Cumming School of Medicine - University of Calgary, Calgary, Alberta; Division of Rheumatology, Department of Medicine, McGill University Health Centre, Montreal, Quebec; Division of Rheumatology, Department of Medicine and Department of Pathology, Queen Elizabeth II Health Sciences Centre and Dalhousie University, Halifax, Nova Scotia; Department of Medicine and Community Health Sciences, University of Manitoba, Winnipeg, Manitoba, Canada; Instituto Nacional de Ciencias Médicas y Nutrición, Mexico City, Mexico; Department of Rheumatology, Hanyang University Hospital for Rheumatic Diseases, Seoul, Korea; Rheumatology Research Group, School of Immunity and Infection, College of Medical and Dental Sciences, University of Birmingham, Birmingham; Centre for Rheumatology Research, University College, London; Lupus Research Unit, The Rayne Institute, St. Thomas' Hospital, King's College London School of Medicine, London; Lanarkshire Centre for Rheumatology, Hairmyres Hospital, East Kilbride, Scotland; Arthritis Research UK Centre for Epidemiology, Centre for Musculoskeletal Research, Faculty of Biology, Medicine and Health, The University of Manchester and UK National Institute for Health Research (NIHR) Manchester Biomedical Research Centre, Manchester University Foundation Trust, Manchester, UK; Cedars-Sinai/David Geffen School of Medicine at University of California at Los Angeles, Los Angeles, California; Department of Clinical Pharmacology, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma; Department of Medicine, State University of New York (SUNY) Downstate Medical Center, Brooklyn, New York; Department of Medicine, Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, Alabama; Department of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, Maryland; Feinstein Institute for Medical Research, Manhasset, New York; Division of Rheumatology and Immunology, Department of Medicine, University of North Carolina, Chapel Hill, North Carolina; Autoimmunity Institute, Allegheny Health Network, Pittsburgh, Pennsylvania; Northwestern University and Feinberg School of Medicine, Chicago, Illinois; Division of Rheumatology, Emory University School of Medicine, Atlanta, Georgia; University of California San Diego School of Medicine, La Jolla, California; Division of Rheumatology, Medical University of South Carolina, Charleston, South Carolina; Division of Rheumatology, Columbia University Medical Center, New York, New York, USA; Department of Rheumatology, Center for Rheumatology Research Fossvogur Landspitali University Hospital, Reyjkavik, Iceland; Autoimmune Disease Unit, Department of Internal Medicine, Hospital Universitario Cruces, BioCruces Health Research Institute, University of the Basque Country, Barakaldo; Josep Font Autoimmune Diseases Laboratory, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Department of Autoimmune Diseases, Hospital Clínic, Barcelona, Spain; Division of Rheumatology, Department of Internal Medicine, Istanbul Medical Faculty, Istanbul University, Istanbul, Turkey; Copenhagen Lupus and Vasculitis Clinic, Centre for Rheumatology and Spine Diseases, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Department of Rheumatology, Kantousspital, Schaffhausen, Switzerland.

View Article

Download full-text PDF

Source
http://www.jrheum.org/lookup/doi/10.3899/jrheum.180713
Publisher Site
http://dx.doi.org/10.3899/jrheum.180713DOI Listing
May 2019

Long-term experience with apremilast in patients with psoriatic arthritis: 5-year results from a PALACE 1-3 pooled analysis.

Arthritis Res Ther 2019 05 10;21(1):118. Epub 2019 May 10.

Rheumatology Clinical Research Division, Swedish Medical Center/Providence St. Joseph Health and University of Washington, Seattle, WA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13075-019-1901-3DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6509758PMC
May 2019

Antimalarial-induced Cardiomyopathy in Systemic Lupus Erythematosus: As Rare as Considered?

J Rheumatol 2019 04 15;46(4):391-396. Epub 2018 Oct 15.

From the University of Toronto Lupus Clinic, Toronto Western Hospital, Centre for Prognosis Studies in the Rheumatic Diseases, University Health Network; University of Toronto, Krembil Research Institute; Department of Cardiology, University of Toronto, Women's College Hospital; Mecklinger Family and Posluns Family Cardiac Catheterization Research Laboratory, Department of Medicine, Division of Cardiology, Mount Sinai Hospital, University of Toronto; Department of Laboratory Medicine and Pathobiology, University Health Network, Toronto General Hospital, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.180124DOI Listing
April 2019

Using Acute-phase Reactants to Inform the Development of Instruments for the Updated Psoriatic Arthritis Core Outcome Measurement Set.

J Rheumatol 2019 03 1;46(3):266-273. Epub 2018 Nov 1.

From the Department of Rheumatology, St. Vincent's University Hospital, Dublin, Ireland; Division of Rheumatology, University of Toronto, Krembil Research Institute, Toronto Western Hospital, Toronto, Ontario, Canada; Department of Rheumatology and Immunology, Singapore General Hospital; Duke-NUS Medical School, Singapore; University Hospitals, Cleveland, Ohio, USA; Conway Institute for Biomolecular Research, University College Dublin, Dublin, Ireland; Johns Hopkins University School of Medicine, Division of Rheumatology, Baltimore, Maryland, USA; Women's College Research Institute, Women's College Hospital; Department of Medicine, University of Toronto, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.180195DOI Listing
March 2019

Outcome of pregnancy in women with psoriatic arthritis compared to healthy controls.

Clin Rheumatol 2019 Mar 7;38(3):895-902. Epub 2018 Dec 7.

Centre for Prognosis Studies in the Rheumatic Diseases, Krembil Research Institute, University Health Network, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s10067-018-4385-7
Publisher Site
http://dx.doi.org/10.1007/s10067-018-4385-7DOI Listing
March 2019

The association between occupational-related mechanical stress and radiographic damage in psoriatic arthritis.

Semin Arthritis Rheum 2019 02 19;48(4):638-643. Epub 2018 Jun 19.

Department of Medicine, University of Toronto, Toronto, ON, Canada; Women's College Research Institute, Women's College Hospital, Toronto, Ontario, Canada. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.semarthrit.2018.06.001DOI Listing
February 2019

Prevalence of psoriatic arthritis in patients with psoriasis: A systematic review and meta-analysis of observational and clinical studies.

J Am Acad Dermatol 2019 Jan 19;80(1):251-265.e19. Epub 2018 Jun 19.

Department of Dermatology and Allergy, Herlev and Gentofte Hospital, University of Copenhagen, Copenhagen, Denmark. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jaad.2018.06.027DOI Listing
January 2019

Abnormal Cardiac Biomarkers in Patients with Systemic Lupus Erythematosus and No Prior Heart Disease: A Consequence of Antimalarials?

J Rheumatol 2019 01 1;46(1):64-69. Epub 2018 Aug 1.

From the Toronto Lupus Clinic, Centre for Prognosis Studies in Rheumatic Diseases, University Health Network; Cardiology Department, Women's College Hospital, University of Toronto, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.171436DOI Listing
January 2019

Correction to: Psoriasis in systemic lupus erythematosus: a single-center experience.

Clin Rheumatol 2019 01;38(1):269

Centre for Prognosis Studies in the Rheumatic Diseases Toronto Western Hospital, University of Toronto Lupus Clinic, University Health Network, 399 Bathurst St. 1E-410B, Toronto, ON, M5T 2S8, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10067-018-4363-0DOI Listing
January 2019

Correction to: The association between sonographic enthesitis and radiographic damage in psoriatic arthritis.

Arthritis Res Ther 2019 Jan 14;21(1):20. Epub 2019 Jan 14.

Department of Medicine, University of Toronto, Women's College Research Institute, Women's College Hospital, Room 6326, 76 Grenville Street, Toronto, ON, M5S 1B2, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13075-019-1814-1DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6330750PMC
January 2019

Ixekizumab and complete resolution of enthesitis and dactylitis: integrated analysis of two phase 3 randomized trials in psoriatic arthritis.

Arthritis Res Ther 2019 01 29;21(1):38. Epub 2019 Jan 29.

NIHR Leeds Biomedical Research Centre, Leeds Teaching Hospitals NHS Trust and Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13075-019-1831-0DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6350390PMC
January 2019

Patterns of peripheral joint involvement in psoriatic arthritis-Symmetric, ray and/or row?

Semin Arthritis Rheum 2018 12 9;48(3):430-435. Epub 2018 Mar 9.

Centre for Prognosis Studies in The Rheumatic Diseases, Krembil Research Institute, University Health Network, University of Toronto, Toronto, Ontario, Canada. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.semarthrit.2018.03.002DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6986918PMC
December 2018

What Is Axial Psoriatic Arthritis?

J Rheumatol 2018 12;45(12):1611-1613

Krembil Research Institute, Toronto Western Hospital, University Health Network; Division of Rheumatology, Department of Medicine, and Institute of Medical Science, University of Toronto, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.180802DOI Listing
December 2018

Back pain in psoriatic arthritis: defining prevalence, characteristics and performance of inflammatory back pain criteria in psoriatic arthritis.

Ann Rheum Dis 2018 11 4;77(11):1573-1577. Epub 2018 Aug 4.

University of Toronto Psoriatic Arthritis Clinic, Centre for Prognostic Studies in the Rheumatic Diseases, Krembil Research Institute, Toronto Western Hospital, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/annrheumdis-2018-213334DOI Listing
November 2018

Ixekizumab improves patient-reported outcomes up to 52 weeks in bDMARD-naïve patients with active psoriatic arthritis (SPIRIT-P1).

Rheumatology (Oxford) 2018 10;57(10):1777-1788

Division of Rheumatology, Department of Medicine, University of Toronto, Krembil Research Institute, Toronto Western Hospital, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/rheumatology/key161DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6152421PMC
October 2018

Practice Variations in the Diagnosis, Monitoring, and Treatment of Systemic Lupus Erythematosus in Canada.

J Rheumatol 2018 10 1;45(10):1440-1447. Epub 2018 Aug 1.

From the Division of Rheumatology, University of Alberta, Edmonton, Alberta; Division of Rheumatology, McGill University, Montreal, Quebec; Alberta Research Centre for Health Evidence, Department of Pediatrics, University of Alberta, Edmonton, Alberta; Division of Rheumatology, CHU de Québec, Université Laval, Quebec City, Quebec; Division of Rheumatology, University of Toronto, Toronto, Ontario; Division of Rheumatology, University of Manitoba, Winnipeg, Manitoba, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.171307DOI Listing
October 2018

Canadian Rheumatology Association Recommendations for the Assessment and Monitoring of Systemic Lupus Erythematosus.

J Rheumatol 2018 10 1;45(10):1426-1439. Epub 2018 Sep 1.

From the Division of Rheumatology, Department of Medicine, University of Alberta, Edmonton, Alberta; Division of Rheumatology, Department of Medicine, University of British Columbia, Vancouver, British Columbia; Division of Rheumatology, Department of Medicine, Cumming School of Medicine, University of Calgary, Calgary, Alberta; Canadian Arthritis Patient Alliance; Division of Rheumatology, Department of Medicine, McGill University; Division of Rheumatology, Department of Medicine, Université de Montréal, Montreal; Division of Rheumatology, Department of Medicine, Université Laval, Quebec City, Quebec; Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto; Division of Rheumatology, Department of Medicine, McMaster University, Hamilton, Ontario; Division of Rheumatology, Department of Medicine, Dalhousie University, Halifax, Nova Scotia; Division of Rheumatology, Hospital for Sick Children, Department of Pediatrics, University of Toronto, Toronto, Ontario; Division of Rheumatology, Department of Medicine, University of Manitoba, Winnipeg, Manitoba; General Internal Medicine, McGill University Health Centre, McGill University, Montreal, Quebec; Cochrane Musculoskeletal Group, University of Ottawa, Ottawa; Division of Rheumatology, Department of Medicine, Western University, London, Ontario; Canadian Agency for Drugs and Technologies in Health, Ottawa; Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton; Centre for Practice-changing Research, Ottawa Hospital Research Institute, Ottawa, Ontario.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.171459DOI Listing
October 2018

Classification and Outcome Measures for Psoriatic Arthritis.

Front Med (Lausanne) 2018 6;5:246. Epub 2018 Sep 6.

Division of Rheumatology and Krembil Research Institute, University Health Network, Toronto Western Hospital, University of Toronto, Toronto, ON, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fmed.2018.00246DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6135872PMC
September 2018

A novel lupus activity index accounting for glucocorticoids: SLEDAI-2K glucocorticoid index.

Rheumatology (Oxford) 2018 08;57(8):1370-1376

Toronto Western Hospital, Centre for Prognosis Studies in the Rheumatic Diseases, University of Toronto Lupus Clinic, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/rheumatology/key103DOI Listing
August 2018

Monophasic Disease Course in Systemic Lupus Erythematosus.

J Rheumatol 2018 08 1;45(8):1131-1135. Epub 2018 Jun 1.

From the Centre for Prognosis Studies in Rheumatic Diseases, Toronto Lupus Clinic, University Health Network, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.171319DOI Listing
August 2018

Physician's Global Assessment in Psoriatic Arthritis: A Multicenter GRAPPA Study.

J Rheumatol 2018 08 15;45(9):1256-1262. Epub 2018 Jun 15.

From the Department of Medical Sciences, Policlinico of the University of Cagliari; Rheumatology Unit, and Department of Public Health, University of Cagliari, Cagliari; Rheumatology Department of Lucania, San Carlo Hospital of Potenza and Madonna delle Grazie Hospital of Matera, Matera; Rheumatology Research Unit, Department of Clinical and Experimental Medicine, University "Federico II," Naples; Department of Rheumatology, ASST Gaetano Pini-Centro Traumatologico Ortopedico (CTO), Milan; Rheumatology Unit, Azienda USL-IRCCS di Reggio Emilia and Università di Modena e Reggio Emilia, Modena and Reggio Emilia; Dipartimento di Medicina e Scienze della Salute, Università degli Studi del Molise, Campobasso, Italy; University of Toronto, Toronto Western Hospital, Toronto, Ontario, Canada; Academic Medical Center/University of Amsterdam; Amsterdam Rheumatology and Immunology Center Reade, Amsterdam, the Netherlands; Rehabilitation Teaching and Research Unit, Department of Medicine, Wellington School of Medicine and Health Sciences, University of Otago, Wellington, New Zealand; Medizinische Klinik III mit Poliklinik, Friedrich-Alexander-Universität Erlangen-Nuernberg, Erlangen, Germany; Sector of Dermatology, HUCFF School of Medicine, Federal University of Rio de Janeiro and Sector of Dermatology, HUPE School of Medical Sciences, State University of Rio de Janeiro, Rio de Janeiro, Brazil; Spondyloarthritis Program, Johns Hopkins University, School of Medicine, Baltimore, Maryland; Swedish Medical Centre and University of Washington School of Medicine, Seattle, Washington, USA; Department of Rheumatology, Semmelweis University, Budapest, Hungary; Leeds Institute of Molecular Medicine, University of Leeds, Leeds, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.171183DOI Listing
August 2018

Prologue: 2017 Annual Meeting of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA).

J Rheumatol Suppl 2018 Jun;94:1-3

From the Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds; Bradford Hospitals UK National Health Service (NHS) Foundation Trust, Bradford, UK; University of Toronto; Krembil Research Institute, Toronto Western Hospital, Toronto, Ontario, Canada; GRAPPA, Seattle, Washington; New York Medical College, Metropolitan Hospital, New York, New York, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.180129DOI Listing
June 2018

Content and Face Validity and Feasibility of 5 Candidate Instruments for Psoriatic Arthritis Randomized Controlled Trials: The PsA OMERACT Core Set Workshop at the GRAPPA 2017 Annual Meeting.

J Rheumatol Suppl 2018 Jun;94:17-25

From the Royal Prince Alfred Hospital Medical Centre, Sydney, Australia; Royal National Hospital for Rheumatic Diseases, Bath, UK; University of Pennsylvania, Philadelphia, Pennsylvania, USA; Department of Rheumatology and Immunology, Singapore General Hospital, Singapore; University of Toronto, Krembil Research Institute, Psoriatic Arthritis Program, University Health Network, Toronto, Ontario, Canada; Department of Dermatology, University of Utah, Salt Lake City, Utah, USA; University of Oxford, Oxford, UK; Swedish Medical Center and University of Washington School of Medicine, Seattle, Washington, USA; Women's College Research Institute, Women's College Hospital, University of Toronto, Toronto, Ontario, Canada; Division of Immunology/Rheumatology, Stanford University, Palo Alto, California, USA; Department of Rheumatology, St. Vincents University Hospital and Conway Institute for Biomolecular Research, University College Dublin, Dublin, Ireland; The Parker Institute, Bispebjerg and Frederiksberg Hospital, The Capital Region of Denmark; Hong Kong Psoriatic Arthritis Association, Hong Kong, China; VU Medical Centre, Amsterdam, the Netherlands; IQVIA, Duke University School of Medicine, Durham, North Carolina, USA; School of Epidemiology, Public Health, and Preventive Medicine, Faculty of Medicine, University of Ottawa, and Ottawa Hospital Research Institute, Clinical Epidemiology Program, Ottawa, Ontario, Canada; Musculoskeletal Health and Outcomes Research, St. Michael's Hospital and Institute for Work and Health, and Department of Occupational Science and Occupational Therapy, Rehabilitation Sciences Institute, and the Institute for Health Policy Management and Evaluation, University of Toronto, Toronto, Ontario, Canada; Division of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.180142DOI Listing
June 2018

The Benefits and Challenges of Setting Up a Longitudinal Psoriatic Arthritis Database.

J Rheumatol Suppl 2018 Jun;94:26-29

From the University of Toronto; Krembil Research Institute; Psoriatic Arthritis Program University Health Network, Toronto Western Hospital, Toronto, Ontario, Canada; Department of Orthopedics, Rheumatology, and Musculoskeletal Sciences, University of Oxford, Oxford; Department of Rheumatology, Cambridge University Hospitals National Health Service (NHS) Foundation Trust, Cambridge; Royal National Hospital for Rheumatic Diseases; University of Bath, Bath, UK; Swedish Medical Center and University of Washington School of Medicine, Seattle, Washington, USA; Department of Rheumatology, Erasmus Medical Center, Rotterdam, the Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.180132DOI Listing
June 2018

Proceedings of the 2017 GRAPPA Collaborative Research Network Meeting.

J Rheumatol Suppl 2018 Jun;94:54-61

From the Rheumatology Research Unit, Cambridge University Hospitals UK National Health Service (NHS) Foundation Trust, Cambridge; University of Leeds, Leeds; Bradford Hospitals NHS Foundation Trust, Bradford, UK; Department of Medicine, Division of Rheumatology, University of Toronto, Toronto Western Hospital, Krembil Research Institute, Toronto, Ontario, Canada; Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania; University of Southern California, Los Angeles, California; University of Utah, Salt Lake City, Utah; Division of Allergy, Immunology, and Rheumatology, University of Rochester Medical Center, Rochester, New York, USA; Our Lady's Hospice and Care Services; Newman Clinical Research Professor, Department of Rheumatology, St. Vincent's University Hospital and Conway Institute for Biomolecular Research, University College Dublin, Dublin, Ireland; Department of Medical Humanities, VU University Medical Centre, Amsterdam, the Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.180141DOI Listing
June 2018

Smoking Is the Most Significant Modifiable Lung Cancer Risk Factor in Systemic Lupus Erythematosus.

J Rheumatol 2018 03 15;45(3):393-396. Epub 2018 Jan 15.

From The Research Institute of the McGill University Health Centre, Montreal; Université de Laval, Service de rheumatologie, Quebec City, Quebec; Toronto Western Hospital, Toronto, Ontario; Dalhousie University and Capital Health, Halifax, Nova Scotia; University of Manitoba, Winnipeg, Manitoba; Division of Rheumatology, University of Calgary, Cumming School of Medicine, Calgary, Alberta, Canada; Northwestern University Feinberg School of Medicine, Chicago, Illinois; Johns Hopkins University School of Medicine, Baltimore, Maryland; University of California at San Francisco, Department of Medicine, San Francisco, California; State University of New York-Downstate Medical Center, Brooklyn; The Feinstein Institute for Medical Research, Manhasset, New York; Therapeutic Radiology, Yale University, New Haven, Connecticut, USA; University of Birmingham, College of Medical and Dental Sciences, Birmingham; University College London, Faculty of Medicine, Department of Rheumatology, London, UK; Lund University Hospital, Lund, Sweden; The Hospital for Rheumatic Diseases, Hanyang University, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.170652DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5834350PMC
March 2018

Gaps in Diagnosis and Treatment of Cardiovascular Risk Factors in Patients with Psoriatic Disease: An International Multicenter Study.

J Rheumatol 2018 03 1;45(3):378-384. Epub 2018 Feb 1.

From the Women's College Research Institute, Women's College Hospital; Department of Medicine, University of Toronto; Centre for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital; Division of Dermatology, University of Toronto, Toronto Western Hospital, Toronto; Western University, London, Ontario; University of British Columbia, Vancouver, British Columbia; Memorial University of Newfoundland, St. John's, Newfoundland; University of Manitoba; Winnipeg Clinic, Winnipeg, Manitoba, Canada; University of Michigan Medical School, Ann Arbor, Michigan; Allergy, Immunology and Rheumatology Division, University of Rochester Medical Center, Rochester, New York, USA; Rheumatology Unit, Carmel Medical Center, Haifa, Israel.

View Article

Download full-text PDF

Source
http://www.jrheum.org/lookup/doi/10.3899/jrheum.170379
Publisher Site
http://dx.doi.org/10.3899/jrheum.170379DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5845845PMC
March 2018

Current and future therapies for SLE: obstacles and recommendations for the development of novel treatments.

Lupus Sci Med 2017 17;4(1):e000239. Epub 2017 Dec 17.

Centre for Prognosis Studies in the Rheumatic Diseases, University of Toronto, Lupus Clinic, Toronto Western Hospital, University Health Network, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/lupus-2017-000239DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5761306PMC
December 2017